Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1995-1999  (839)
  • General Chemistry  (600)
  • Computational Chemistry and Molecular Modeling
  • pharmacokinetics
  • 1
    Electronic Resource
    Electronic Resource
    Sequential administration of temozolomide and fotemustine: Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours (1999)
    Springer
    Annals of oncology 10 (1999), S. 831-838 
    Details
    ISSN: 1569-8041
    Keywords: melanoma ; pharmacodynamics ; pharmacokinetics ; temozolomide
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: The DNA repair protein O6-alkylguanine-DNA alkyl transferase (AT) mediates resistance to chloroethylnitrosoureas. Agents depleting AT such as DTIC and its new analogue temozolomide (TMZ) can reverse resistance to chloroethylnitrosoureas. We report the results of a dose finding study of TMZ in association with fotemustine. Patients and methods: Twenty-four patients with metastatic melanoma or recurrent glioma were treated with escalating dose of oral or intravenous TMZ ranging from 300 to 700 mg/m2, divided over two days. Fotemustine 100 mg/m2 was given intravenously on day 2, 4 hours after TMZ. AT depletion was measured in peripheral blood mononuclear cells (PBMCs) and in selected cases in melanoma metastases and was compared to TMZ pharmacokinetics. Results: The maximum tolerated dose (MTD) of TMZ was 400 mg/m2 (200 mg/m2/d) when associated with fotemustine the 2nd day with myelosuppression as dose limiting toxicity. The decrease of AT level in PBMCs was progressive and reached 34% of pretreatment values on day 2. There was however wide interindividual variability. AT reduction was neither dose nor route dependent and did not appear to be related to TMZ systemic exposure (AUC). In the same patients, AT depletion in tumour did not correlate with the decrease of AT observed in PBMCs. Conclusions: PBMCs may not be used as a surrogate of tumour for AT depletion. Further study should concentrate on the pharmacokinetic pharmacodynamic relationship in tumour to provide the basis for individually tailored therapy.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1023/A:1008304032421
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion (1997)
    Springer
    Annals of oncology 8 (1997), S. 385-391 
    Details
    ISSN: 1569-8041
    Keywords: carboplatin ; cisplatin ; intrapleural combination ; pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: Cisplatin (DDP) and carboplatin (CBDCA) are two of the mosteffective drugs in a locoregional approach. Since simultaneous combinedtreatment with intrapleural DDP and CBDCA has not been reported in humans, weinvestigated its use in patients with malignant effusions, focusing onpharmacokinetics. Patients and methods: The pharmacokinetics of DDP and CBDCA were studiedin 10 patients with malignant pleural effusion treated intrapleurally with acombination of DDP (60 mg/m2) and CBDCA (270mg/m2) and in additional patients who received the same dosesof drugs administered intravenously as single agents or in combination.Platinum (Pt) species originating from DDP (metabolites plus unchanged DDP)and intact CBDCA in plasma and pleural fluid ultrafiltrates were measured bymeans of high performance liquid chromatography and atomic absorptionspectrometry. Results: Both in the plasma and pleural fluid, the total levels of free Ptrepresented the additive result of the individual concentrations of CBDCA andPt-species derived from DDP. After intrapleural combination, highpleural-plasma ratios of the peak concentrations and AUCs were observed bothfor CBDCA and DDP-derived Pt species, highlighting a distinct localpharmacological advantage. However, the Pt species originating from DDP wereabsorbed more rapidly from the pleural cavity than CBDCA (Ka= 86 × 10-3 vs. 37 ×10-3 min-1, P 〈 0.05).Intrapleural combination of CBDCA and DDP produced therapeutic plasma levelsof reactive (free) DDP species and increased the extent of their residencetime (MRT) compared with single intravenous DDP treatment [peak concentration:1.1 ± 0.1 (SD) vs. 1.6 ± 0.2 µg/ml; MRT: 5.2 ± 1.9vs. 0.5 ± 0.06 h]. Furthermore, the plasma AUC of free CBDCA afterintrapleural combined treatment (2.1 ± 0.5 mg/ml × min) wassimilar to that after intravenous administration of CBDCA alone (2.1 ±0.2 mg/ml × min). The intrapleural treatment was well tolerated by allpatients. Toxicity consisted of mild nausea and vomiting (grade 1–2according to the WHO scale) in four patients. Myelosuppression (grade1–2) was remarkable only in two heavily pretreated patients. No evidenceof recurrence of the pleural effusion was observed in six patients (completeresponse), while an asymptomatic minimal fluid reaccumulation not requiringdrainage (partial response) was observed in four patients. Conclusions: The pharmacologic results seem to exclude a pharmacokineticinteraction between CBDCA and DDP and suggest that a dose of CBDCA 2-foldhigher than that used in this study associated intrapleurally with 60mg/m2 DDP could induce an acceptable and predictablemyelosuppresion.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1023/A:1008203100410
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 3
    Electronic Resource
    Electronic Resource
    Insertion Reactions into Palladium-Carbon Bonds of Complexes Containing Terdentate Nitrogen Ligands; Experimental and Ab initio MO Studies (1998)
    Weinheim : Wiley-Blackwell
    Berichte der deutschen chemischen Gesellschaft 1998 (1998), S. 1129-1143 
    Details
    ISSN: 1434-1948
    Keywords: Insertion ; N ligands ; Terdentate ligands ; Rigid ligands ; Palladium ; Chemistry ; General Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Notes: Novel methyl complexes [Pd(Me)(N-N-N)]X (N-N-N = flexible or rigid terdentate nitrogen ligand, X = Cl, SO3CF3, BAr′4) have been synthesized and fully characterized. All complexes readily underwent insertion of carbon monoxide resulting in the quantitative formation of complexes [Pd{C(O)Me}(N-N-N)]X [X = Cl (1d-6d), BAr′4 (1e-6e)]. Subsequently, complexes 2e-6e underwent quantitative insertion of norbornadiene, resulting in complexes [Pd{C7H8C(O)Me}(N-N-N)]BAr′4 (2f-6f). Unexpectedly, these complexes, including even those containing rigid terdentate nitrogen ligands, possess a structure in which the nitrogen ligand is coordinated in a bidentate fashion. A kinetic study of the reaction of norbornadiene with complexes 1e-6e revealed that the reactivity of complexes 1e-6e toward norbornadiene increases with increasing rigidity of the terdentate ligand, i.e. with increasing strain in the PdN3 moiety, which indicates that insertion very likely occurs via a mechanism involving nitrogen dissociation. This is fully supported by ab initio MO calculations on CO and ethylene insertion into carbon-palladium bonds of cationic model systems containing a rigid terdentate nitrogen ligand, which showed that the lowest-energy pathway for both insertion reactions consists of substitution of one of the distal nitrogen atoms of the rigid terdentate nitrogen ligand by the substrate, followed by a rate-determining migratory insertion of the substrate into the carbon-palladium bond.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
  • 4
    Electronic Resource
    Electronic Resource
    Methyl Aryl Ketones in the Synthesis of Hexaazabicycloicosane Cage ComplexesThis paper is dedicated to Gottfried Huttner, a stimulating teacher, researcher and companion (1997)
    Weinheim : Wiley-Blackwell
    Chemistry - A European Journal 3 (1997), S. 1283-1291 
    Details
    ISSN: 0947-6539
    Keywords: cage compounds ; cobalt ; cyclic voltammetry ; fluorescence spectroscopy ; template synthesis ; Chemistry ; General Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Notes: The template syntheses of various CoIII-hexaazaicosane-type cage complexes with aromatic substituents are described. The parent template, [Co(sen)]3+ ion {sen = 4,4′,4″-ethylidynetris(3-azabutan-1-amine)}, paraformaldehyde, a methyl aryl ketone and a base were reacted in acetonitrile to give aroyl substituents attached to the fully saturated sarcophagine cage (1-aroyl-8-methyl-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-icosane cobalt(III) ion) and aryl substituents attached to an analogous imine-type cage (2-aryl-8-methyl-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosa-2-ene cobalt(III) ion). Phenyl, napthyl, phenanthryl, anthracenyl and anthraquinonyl substituents have been bound to the cage simply by this route to give molecules that can act as intercalators in DNA or as photosensitizers attached to reversible redox-active metal centres and can couple an organic two-electron reagent with an inorganic one-electron reagent. An X-ray crystallographic analysis of a phenanthroyl cage complex has also been carried out. These substances and their progeny should be useful as biological probes and fluorescent indicators and for energy capture and conversion.
    Additional Material: 5 Ill.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1002/chem.19970030816
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 5
    Electronic Resource
    Electronic Resource
    Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist (1995)
    Springer
    European journal of clinical pharmacology 49 (1995), S. 115-119 
    Details
    ISSN: 1432-1041
    Keywords: Losartan ; Cimetidine ; pharmacokinetics ; plasma renin activity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Abstract This was a 2-period randomized, crossover study in 8 healthy males to determine the effects of cimetidine (400 mg q.i.d. for 6 days) on the pharmacokinetics and pharmacodynamic effects of the angiotensin II receptor antagonist, losartan (100 mg). Cimetidine increased the AUC for losartan 18% without affecting the AUC for E-3174, the active metabolite of losartan. The increase in plasma renin activity following losartan was not affected by cimetidine (maximum mean increases 12.6 and 12.1 ng Ang I·ml−1·h−1 without and with cimetidine, respectively). These results indicate that cimetidine does not appear to alter the pharmacokinetics or pharmacodynamics of losartan to a clinically significant extent.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00192369
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 6
    Electronic Resource
    Electronic Resource
    Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment (1997)
    Springer
    European journal of clinical pharmacology 52 (1997), S. 229-234 
    Details
    ISSN: 1432-1041
    Keywords: Key words Ranitidine ; Renal impairment; dose adjustment ; pharmacodynamics ; pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Abstract Objective: The pharmacodynamics and pharmacokinetics of ranitidine were examined in subjects with varying degrees of renal function to determine the effect of this condition on acid-antisecretory activity. Methods: Subjects with creatinine clearances (CCr) ranging from 0 to 213 ml · min−1 received single 50-mg and 25-mg i.v. doses of ranitidine. This was followed by determination of serum and urine ranitidine concentrations, and continuous gastric pH monitoring for 24 h. Results: Serum ranitidine concentrations were described by a two-compartment model linked to a sigmoidal Emax model describing gastric pH. Ranitidine renal clearance, ranging from 0 to 1003 ml · min−1, correlated with CPAH (r 2 = 0.707), while non-renal clearance was unaltered. Steady-state volume of distribution decreased by half in severe renal impairment. No changes in the effective concentration at half-maximal response (EC50), maximal response (Emax), or basal response (E0) were observed. Thus, renal elimination of ranitidine declined in parallel with renal function, while sensitivity to the pharmacologic effect (gastric pH elevation) was unaltered. Ranitidine was well tolerated in these renally impaired subjects. Conclusion: These data indicate that the current recommendation for renal impairment dose reduction (by two-thirds when CCr〈50 ml · min−1) might result in under-treating moderately impaired patients, and suggests a less conservative dose reduction (by half when CCr〈10 ml · min−1) to avoid therapeutic failure while remaining within the wide margin of safety for this drug.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/s002280050279
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 7
    Electronic Resource
    Electronic Resource
    Application of a Combined “Effect Compartment/Indirect Response Model” to the Central Nervous System Effects of Tiagabine in the Rat (1999)
    Springer
    Journal of pharmacokinetics and pharmacodynamics 27 (1999), S. 301-323 
    Details
    ISSN: 1573-8744
    Keywords: pharmacokinetics ; pharmacodynamics ; effect compartment model ; indirect response ; sigmoid E max ; tiagabine ; GABA uptake inhibitor
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract Pharmacological inhibition of GABA uptake transporters provides a mechanism for increasing GABAergic transmission, which may be useful in the treatment of various neurological disorders. The purpose of our investigations was to develop an integrated pharmacokinetic–pharmacodynamic (PK/PD) model for the characterization of the pharmacological effect of tiagabine, R-N-(4,4-di-(3-methylthien-2-yl)but-3-enyl)nipecotic acid, in individual rats in vivo. The tiagabine-induced increase in the amplitude of the EEG 11.5–30 Hz frequency band (β), was used as pharmacodynamic endpoint. Chronically instrumented male Wistar rats were randomly allocated to four groups which received an infusion of 3, 10, or 30 mg kg −1 $$(\bar x \pm SE,{\text{ }}n = 23)$$ $$96 \pm 9$$ ml min -1 kg−1, 1.5ŷ0.1 L kg−1 and 20ŷ0.2 min.A time delay was observed between the occurrence of maximum plasma drug concentrations and maximal response. A physiological PK/PD model has been used to account for this time delay, in which a biophase was postulated to account for tiagabine available to the GABA uptake carriers in the synaptic cleft and the increase in EEG effect was considered an indirect response due to inhibition of GABA uptake carriers. The population values for the pharmacodynamic parameters characterizing the delay in pharmacological response relative to plasma concentrations were keo=0.030 min −1 and kout=81 min−1, respectively. Because of the large difference in these values the PK/PD model was simplified to the effect compartment model. Population estimates $$(\bar x \pm SE)$$ were E0=155 ŷ 6 μV, Emax=100 ŷ 5 μV, EC50=287 ŷ 7 ng ml−1, Hill factor=1.8 ŷ 0.2 and keo=0.030 ŷ 0.002 min −1. The results of this analysis show that for tiagabine the combined “effect compartment-indirect response” model can be simplified to the classical “effect compartment” model.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1023/A:1020999114109
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 8
    Electronic Resource
    Electronic Resource
    Exploration of High-Pressure Cycloadducts of Furans and Citraconic Anhydride as Precursors for CD-Ring Fragments of Paclitaxel and Its Analogues (1998)
    Weinheim : Wiley-Blackwell
    Liebigs Annalen 1998 (1998), S. 2483-2492 
    Details
    ISSN: 1434-193X
    Keywords: Paclitaxel (Taxol®) ; Paclitaxel CD-ring ; High-pressure Diels-Alder reactions ; Furan cycloadditions ; Ether cleavage in 7-oxabicyclo[2.2.1]heptanes ; Chemistry ; General Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Notes: The high-pressure promoted Diels-Alder reactions between several furans and citraconic anhydride have been studied and the cycloadducts obtained have been explored in new straightforward routes to the CD-ring fragment of paclitaxel. The reaction between furan and citraconic anhydride afforded the exo cycloadduct diastereoselectively, whereas a variety of 2-substituted furans afforded approximate 1:1 mixtures of exo regioisomers. Separation of both regioisomers was accomplished after either diastereoselective esterification or regioselective reduction of the anhydride function. Ether cleavage of the bicyclic compounds by either high-pressure promoted ether cleavage or Boord elimination afforded several potential CD-ring precursors which can be used in the total synthesis of paclitaxel analogues.
    Additional Material: 2 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
  • 9
    Electronic Resource
    Electronic Resource
    Supramolecular Structure, Physical Properties, and Langmuir-Blodgett Film Formation of an Optically Active Liquid-Crystalline Phthalocyanine (1995)
    Weinheim : Wiley-Blackwell
    Chemistry - A European Journal 1 (1995), S. 171-182 
    Details
    ISSN: 0947-6539
    Keywords: chiral mesophases ; Langmuir-Blodgett films ; liquid crystals ; phthalocyanines ; supramolecular chemistry ; Chemistry ; General Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Notes: The structure and physical properties of optically active, metal-free 2,3,9,10,16,17,23,24-octa (S-3,7-dimethyloctoxy)phthalocyanine ((S)-Pc(8,2)) are reported and compared with those of the phthalocyanine with (R,S) side chains (mixture of 43 stereoisomers). Unlike the latter compound, (S)-Pc(8,2) lacks a crystalline phase. A freshly prepared sample is in a distorted mesophase and reorganizes irreversibly to a more ordered phase above 65 °C. X-ray diffraction and circular dichroism studies indicate that the molecules are stacked in columns which have a hexagonal arrangement and a left-handed helical superstructure, that is, a novel chiral Dh* mesophase. Solid state NMR measurements reveal that the phthalocyanine units in the columns begin to vibrate laterally when the temperature is increased. At 111 °C (Dh* → Dr transition) they start to rotate around their columnar axes and at the same time the side chains become liquidlike. Energy migration is very efficient in the chiral Dh* phase and also in the frozen mesophase below 3 °C, as follows from luminescence spectroscopy. Intracolumnar charge transport, studied by the time-resolved microwave conductivity technique, turns out to be slower in the helically distorted columns than in linear columns. (S)-Pc(8,2) forms a very stable bilayer at the air-water interface, which can be transferred to give a high quality Langmuir-Blodgett film. The fact that this phthalocyanine is mesogenic at room temperature is thought to be responsible for this behavior.
    Additional Material: 14 Ill.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1002/chem.19950010306
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 10
    Electronic Resource
    Electronic Resource
    Diversity in Complexation of [RhI(cod)]+ and [IrI(cod)]+ by Pyridine-Amine-Pyrrole Ligands (1999)
    Weinheim : Wiley-Blackwell
    Berichte der deutschen chemischen Gesellschaft 1999 (1999), S. 1581-1592 
    Details
    ISSN: 1434-1948
    Keywords: Rhodium ; Iridium ; N ligands ; Coordination modes ; Polymerizations ; Chemistry ; General Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Notes: Complexation of [RhI(cod)]+ and [IrI(cod)]+ by the new pyridine-amine-pyrrole ligands Py-CH2-N(R)-CH2-Pyr-H (HLR; R = H, Bzl, Bu) and the corresponding pyridine-amine-pyrrolate ligands [Py-CH2-N(R)-CH2-Pyr]- (LR-; R = H, Bzl, Bu, CH2Py) has been investigated. The neutral ligands HLR (R = H, Bu, Bzl) give [(HLR)MI(cod)]+ (M = Rh, Ir) in which HLR acts as a didentate ligand via the pyridine nitrogen (NPy) and the amine nitrogen (NRamine). The crystal structures of [(HLH)MI(cod)]PF6 (M = Rh: [1]PF6 and M = Ir: [2]PF6) have been determined. Deprotonation of [(HLR)MI(cod)]+ (M = Rh, Ir; R = H, Bzl, Bu) results in the neutral complexes [(LR)MI(cod)] (M = Rh, Ir) of the mono-anionic ligands LR- (R = H, Bzl, Bu). In square-planar [(LH)MI(cod)] (M = Rh: 3, M = Ir: 4), LH- is didentate via NHamine and the pyrrolate nitrogen (NPyr). The X-ray structures of 3 and 4 reveal that in both cases the uncoordinated NPy accepts a hydrogen bond from NHamine. The X-ray structures of [(LBzl)MI(cod)] (M = Rh: 5, M = Ir: 6), show that LBzl- is didentate via Namine and NPyr for M = Rh and tridentate for M = Ir. In solution LBzl- is tridentate for both M = Rh and M = Ir. The neutral complexes [{Py-CH2-N(R)-CH2-Pyr}MI(cod)] (M = Rh, Ir) cannot be oxidised selectively with H2O2. This is in marked contrast to the previously observed selective oxidation of the corresponding cationic complexes [{Py-CH2-N(R)-CH2-Py}RhI(cod)]+. Rhodium complex 5 is an active catalyst for the stereoregular polymerisation of phenylacetylene, whereas iridium complex 6 is inactive.
    Additional Material: 6 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...